UK deal makes Novartis cancer cell therapy available to kids

Health authorities in England have agreed with Swiss drugmaker Novartis to fast-track access to its expensive CAR-T cell therapy Kymriah and make it available to children and young people with aggressive leukaemia when other drugs have failed.